Strikingly, current studies demonstrate an impaired type I IFN response associated with severe and critical COVID-19 patients, which inversely correlates with an excessive NF-κB–driven inflammatory response associated with increased TNFα and other inflammatory cytokines. Here, NFKB1 is linked to COVID-19.